Advertisement

Topics

Ligand pens Captisol deal with Amgen

15:40 EDT 21 Jul 2017 | Elsevier Business Intelligence

Ligand Pharmaceuticals Inc. licensed Amgen Inc. exclusive global rights to use its Captisol drug delivery technology (which L...

Original Article: Ligand pens Captisol deal with Amgen

NEXT ARTICLE

More From BioPortfolio on "Ligand pens Captisol deal with Amgen"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...